The expression of S100A8 and S100A9 was consistent with single-gene RNA sequencing results, confirming that the expression levels of these two hub genes are significantly upregulated in patients with CAVD (p < 0.01). The gene discussed is S100A9; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.